Drug Trial Radar · NCT04072354
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
Last checked: Nov 20, 2026Latest source record: May 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
463
Actual
Start
Sep 17, 2019
Primary completion
May 12, 2023
Study completion Sep 12, 2023
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Aug 28, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 13 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia. Participants in the study will either receive the drug being studied or a placebo. This study is accepting male and female participants between 13 years old -65 years old who have been diagnosed with schizophrenia.
Conditions
- Schizophrenia
Interventions
SEP-363856 50mgDrug
SEP-363856 50mg tablet dosed once daily
SEP-363856 75mgDrug
SEP-363856 75mg tablet dosed once daily
PlaceboDrug
Placebo tablet dosed once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in PANSS Total Score at Week 6Time frame: Baseline, Week 6
Locations
53 sites in 6 countries. Site status is shown where the registry gives one.
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Bellflower, California
Research Site
Lemon Grove, California
Research Site
Long Beach, California
Research Site
Montclair, California
Research Site
Pico Rivera, California
Research Site
San Diego, California
Research Site
Hollywood, Florida
Research Site
Hollywood, Florida
Research Site
Miami Springs, Florida
Research Site
Atlanta, Georgia
Research Site
Atlanta, Georgia
Research Site
Decatur, Georgia
Research Site
Gaithersburg, Maryland
Research Site
Flowood, Mississippi
Research Site
Dayton, Ohio
Research Site
Austin, Texas
Research Site
Pazardzhik, Bulgaria
Research Site
Pleven, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Veliko Tarnovo, Bulgaria
Research Site
Vratsa, Bulgaria
Research Site
Bogotá, Colombia
Research Site
Bogotá, Colombia
Research Site
Bello, Antioquia, Colombia
Research Site
Chelyabinsk, Russia
Research Site
Moscow, Russia
Research Site
Nizniy Novgorod, Russia
Research Site
Petrozavodsk, Russia
Research Site
Saint Petersburg, Russia
Research Site
Saint Petersburg, Russia
Research Site
Samara, Russia
Research Site
Saratov, Russia
Research Site
Belgrade, Serbia
Research Site
Gornja Toponica, Serbia
Research Site
Kovin, Serbia
Research Site
Kragujevac, Serbia
Research Site
Niš, Serbia
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.